• Home
  • Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.

Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma.

Author List
Liang Y, Bollen AW, Aldape KD, Gupta N
Publication
BMC cancer
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1448082
Publication Year
2006
PubMed ID
16623952
Publication Title
Liang Y, Bollen AW, Aldape KD, Gupta N. Nuclear FABP7 immunoreactivity is preferentially expressed in infiltrative glioma and is associated with poor prognosis in EGFR-overexpressing glioblastoma. BMC Cancer. 2006 Apr 19; 6:97.